These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4982436)

  • 1. [Note on a clinical trial of rifampicin in the treatment of pulmonary tuberculosis].
    Robustelli Pisani F
    G Ital Mal Torace; 1969; ():Suppl 2:85+. PubMed ID: 4982436
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rifampicin in the treatment of patients with chronic destructive tuberculosis complicated by drug intolerance and Mycobacterium drug resistance].
    Adamovich VN; Kolomytseva OS; Gur'ian IE
    Vrach Delo; 1975 Jan; (1):95-9. PubMed ID: 806177
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of rifampicin in pulmonary tuberculosis].
    Massola U; Vercellino A; Vercellino E
    G Ital Mal Torace; 1969; ():Suppl 2:78-84. PubMed ID: 5357147
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rifampicin treatment for pulmonary tuberculosis--effectiveness of rifampicin on tubercle bacilli in pulmonary lesions (author's transl)].
    Kameda K; Okamura S; Yamamoto S; Iwai K
    Kekkaku; 1975 Jul; 50(7):185-9. PubMed ID: 810614
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental and clinical studies of rifampicin in tuberculosis.
    Konno K; Oizumi K; Hayashi I; Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):110-20. PubMed ID: 5004309
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial of rifampicin in the treatment of pulmonary tuberculosis in Lagos.
    Makanjuola OO
    Niger Med J; 1973 Jul; 3(3):156-7. PubMed ID: 16366352
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of intermittent biweekly treatment with rifampicin and ethambutol in silicotuberculosis].
    Dobre V; Silaghi I; Ulbrecht L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(1):39-46. PubMed ID: 223222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of rifampicin on the L transformation of a mycobacterial population in patients with destructive pulmonary tuberculosis].
    Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE; Kiazimova LM
    Probl Tuberk; 1986; (9):31-4. PubMed ID: 3097632
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical significance of the critical drug concentration of rifampicin. Report 2. Clinical investigation: the emergence and reversion of resistance (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1976 Jan; 51(1):7-12. PubMed ID: 815710
    [No Abstract]   [Full Text] [Related]  

  • 11. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
    Constans P; Parrot R; Coury C
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anatomic and bacteriologic testing of rifampicin effectiveness in treatment of pulmonary tuberculosis].
    Morère P; Stain JP; Hubert J; Chauvet MC
    Rev Tuberc Pneumol (Paris); 1970; 34(3):434-8. PubMed ID: 4994941
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of follow-up on advanced cases of pulmonary tuberculosis converted to negative with rifampicin treatment].
    Yamamoto M; Isoe K; Nakamura H; Hirose H; Izumi S
    Kekkaku; 1972 Nov; 47(11):393-7. PubMed ID: 4630902
    [No Abstract]   [Full Text] [Related]  

  • 15. [The sensitivity of Mycobacterium tuberculosis to rifampicin and its clinical effectiveness (author's transl)].
    Chen HL
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Feb; 3(2):104-5. PubMed ID: 6774865
    [No Abstract]   [Full Text] [Related]  

  • 16. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN].
    Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampicin in the retreatment and original treatment of advanced pulmonary tuberculosis.
    Gyselen A
    Bull Int Union Tuberc; 1970 Jun; 43():60-3. PubMed ID: 4987555
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H; Watanabe Y; Yamanaka M; Moriguchi T; Fujii K; Uenoyama T
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C; Timoşca S; Petreanu V; Petreanu C; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
    [No Abstract]   [Full Text] [Related]  

  • 20. [A long-term observation on previously treated cases of pulmonary tuberculosis retreated with rifampicin for more than six months (author's transl)].
    Tamura M; Takazawa N; Asada T; Ikegaki H; Yamada M; Kushiro S; Tada T
    Kekkaku; 1979 May; 54(5):285-95. PubMed ID: 113607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.